Barwniki komórkowe i sondy
- WSHT Bio | 10mL | CRP229 | DAPI staining solution (5ug/mL)
- WSHT Bio | 50mL | CRP229 | DAPI staining solution (5ug/mL)
- WSHT Bio | 10mL | CRP230 | Ready to use DAPI staining solution(10ug/mL)
- WSHT Bio | 50mL | CRP230 | Ready to use DAPI staining solution(10ug/mL)
- WSHT Bio | 10*1mL | CRP231 | DAPI staining solution (1mg/mL)
- WSHT Bio | 1mL | CRP231 | DAPI staining solution (1mg/mL)
- WSHT Bio | 100mL | CRP235 | Trypan blue stain solution(0.4%)
- WSHT Bio | 50mL | CRP235 | Trypan blue stain solution(0.4%)
- WSHT Bio | 100mL | CRP242 | Evans blue stain solution (0.5%)
- WSHT Bio | 500mL | CRP242 | Evans blue stain solution (0.5%)
- Cayman | 10 mg | 11315-10 | Chromomycin A3
- Cayman | 100 mg | 25545-100 | Acridine Orange 10-nonyl (bromide)
- Cayman | 1 mg | 28789-1 | tris-NTA (trifluoroacetate salt)
- Cayman | 500 µg | 28789-500 | tris-NTA (trifluoroacetate salt)
- Cayman | 100 mg | 31634-100 | MH 148
- Cayman | 50 mg | 31634-50 | MH 148
- Cayman | 500 mg | 31634-500 | MH 148
- Cayman | 1 mg | 35876-1 | CCP-biotin Peptide (non-cyclized)
- Cayman | 1 mg | 36879-1 | Mca-SEVNLDAEFR-K(Dnp)-RR-NH2 (acetate)
- Cayman | 10 mg | 36879-10 | Mca-SEVNLDAEFR-K(Dnp)-RR-NH2 (acetate)
- Cayman | 5 mg | 36879-5 | Mca-SEVNLDAEFR-K(Dnp)-RR-NH2 (acetate)
- Cayman | 1 mg | 36887-1 | Mca-RPPGFSAFK(Dnp)-OH (trifluoroacetate salt)
- Cayman | 10 mg | 36887-10 | Mca-RPPGFSAFK(Dnp)-OH (trifluoroacetate salt)
- Cayman | 5 mg | 36887-5 | Mca-RPPGFSAFK(Dnp)-OH (trifluoroacetate salt)
- Cayman | 1 mg | 36896-1 | EGFR Peptide (human, mouse) (trifluoroacetate salt)
- Cayman | 5 mg | 36896-5 | EGFR Peptide (human, mouse) (trifluoroacetate salt)
- Cayman | 1 mg | 36965-1 | Mca-KPLGL-Dap(Dnp)-AR-NH2 (trifluoroacetate salt)
- Cayman | 10 mg | 36965-10 | Mca-KPLGL-Dap(Dnp)-AR-NH2 (trifluoroacetate salt)
- Cayman | 25 mg | 36965-25 | Mca-KPLGL-Dap(Dnp)-AR-NH2 (trifluoroacetate salt)
- Cayman | 5 mg | 36965-5 | Mca-KPLGL-Dap(Dnp)-AR-NH2 (trifluoroacetate salt)
- Cayman | 1 mg | 36969-1 | Abl Substrate Peptide (trifluoroacetate salt)
- Cayman | 10 mg | 36969-10 | Abl Substrate Peptide (trifluoroacetate salt)
- Cayman | 25 mg | 36969-25 | Abl Substrate Peptide (trifluoroacetate salt)
- Cayman | 5 mg | 36969-5 | Abl Substrate Peptide (trifluoroacetate salt)
- Cayman | 1 mg | 36997-1 | 5-FAM-LPETGG (trifluoroacetate salt)
- Cayman | 10 mg | 36997-10 | 5-FAM-LPETGG (trifluoroacetate salt)
- Cayman | 25 mg | 36997-25 | 5-FAM-LPETGG (trifluoroacetate salt)
- Cayman | 5 mg | 36997-5 | 5-FAM-LPETGG (trifluoroacetate salt)
- Cayman | 1 mg | 37002-1 | Mca-AVLQSGFR-K(Dnp)-K-NH2 (trifluoroacetate salt)
- Cayman | 10 mg | 37002-10 | Mca-AVLQSGFR-K(Dnp)-K-NH2 (trifluoroacetate salt)
- Cayman | 5 mg | 37002-5 | Mca-AVLQSGFR-K(Dnp)-K-NH2 (trifluoroacetate salt)
- Cayman | 100 mg | 37140-100 | 2-p-Toluidinylnaphthylene-6-sulfonate (sodium salt)
- Cayman | 250 mg | 37140-250 | 2-p-Toluidinylnaphthylene-6-sulfonate (sodium salt)
- Cayman | 50 mg | 37140-50 | 2-p-Toluidinylnaphthylene-6-sulfonate (sodium salt)
- Cayman | 500 mg | 37140-500 | 2-p-Toluidinylnaphthylene-6-sulfonate (sodium salt)
- Cayman | 1 mg | 37374-1 | FALGPA (trifluoroacetate salt)
- Cayman | 10 mg | 37374-10 | FALGPA (trifluoroacetate salt)
- Cayman | 25 mg | 37374-25 | FALGPA (trifluoroacetate salt)
- Cayman | 5 mg | 37374-5 | FALGPA (trifluoroacetate salt)
- Cayman | 1 mg | 37409-1 | Dabcyl-K-SARS-CoV-2 Replicase Polyprotein 1ab (3235-3246)-E-EDANS (trifluoroacetate salt)